For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

Date published: August 2011
People with atrial fibrillation are more likely to develop a blood clot in their heart. The blood clot can then move to the brain and cause a stroke.
Dabigatran reduces the tendency of blood to clot and, in turn, the risk of having a stroke. It belongs to a group of medicines called anticoagulants.
Dabigatran is an alternative to warfarin for preventing strokes. As with other anticoagulant medicines, there is a risk of serious bleeding. Some serious bleeds may be life-threatening.
Dabigatran is a capsule that you take twice a day. For most people there is a standard dose. There is no need for a blood test to monitor how well it’s working or to adjust the dabigatran dose as there is with the standard anticoagulant treatment, warfarin.
Because dabigatran is a new medicine, the full range of potential side effects is not yet known.
The active ingredient is the chemical in the medicine that makes the medicine work.
Many medicines are known by their brand names as well as by the name of the active ingredient. Some medicines are available under several different brand names.
The active ingredient of this medicine is dabigatran (pronounced da-BIG-a-tran). It is also known by the brand name Pradaxa.
Dabigatran can also be used after hip or knee surgery.
People with atrial fibrillation are at greater risk of having a stroke than other people.
Dabigatran is used to help prevent a stroke in people with atrial fibrillation.
Atrial fibrillation is a fast, irregular heartbeat that can lead to a blood clot forming in the heart. If the blood clot moves from the heart to the brain, it can block small blood vessels and cause a stroke.
Talk with your health professional about all the treatment options for preventing stroke.
Other factors that can increase your risk of stroke are:
You can be prescribed dabigatran for stroke prevention if:
But dabigatran may not be suitable for you if you have:
Your doctor will need to take these into consideration before prescribing dabigatran.
It is important that you take dabigatran twice a day — one capsule in the morning and one at night.
Swallow the dabigatran capsule with water. It can be taken with or without food.
Do not chew the dabigatran capsule or break it open.
Talk to your doctor or pharmacist if you forget to take your dabigatran capsule. Do not take a double dose as this will increase your chance of bleeding.
Unlike warfarin, there is a standard dose for most people.
The standard strength capsule contains 150 mg of dabigatran.
A lower strength 110 mg capsule may be prescribed for:
Dabigatran for the prevention of stroke is likely to be a long-term treatment.
You should not stop taking dabigatran unless your doctor advises you to.
Anticoagulants are sometimes called blood thinners.
Dabigatran helps to prevent a stroke in people with atrial fibrillation by reducing the chances of a blood clot forming.
Dabigatran is a type of medicine called an anticoagulant. Anticoagulants reduce the tendency of blood to clot.
It’s important to note that dabigatran doesn’t treat the fast, irregular heartbeat of atrial fibrillation. Your doctor will prescribe other medicines or treatments for this.
For a list of possible side effects, see the consumer medicine information (CMI) leaflet for dabigatran.
Ask your doctor about the possible side effects of dabigatran before you use it.
You can also discuss side effects with a pharmacist, by calling the Adverse Medicines Event (AME) Line on 1300 134 237 (Mon–Fri, 9am–5pm).
The terms very common, common and uncommon are used to describe the chance of getting a side effect. This is what they mean:
A clinical trial is a research study conducted with patients, which compares one treatment with one or more other treatments, to assess its effectiveness and safety. To find out more about clinical trials, see What are clinical trials and why are they important?
The most significant risk for dabigatran and other anticoagulant medicines is bleeding (see Serious bleeding is a risk with dabigatran and warfarin). Some serious bleeds may be life-threatening.
You should seek urgent medical attention if you have:
Internal bleeding is harder to detect. Contact your doctor immediately or go to the emergency department at your nearest hospital if you experience any of the following:
If you experience any serious injury, you are at greater risk of internal bleeding. You must get immediate medical attention, particularly if you hit your head.
Dabigatran can cause indigestion.
Speak to your health professional about ways to manage indigestion if it affects you. For example, taking dabigatran with food may help.
Dabigatran has been tested in clinical trials, but the full range of potential side effects is not yet known. You should be aware of this and see your doctor straight away if you have any changes in your health or unusual symptoms after starting dabigatran.
An interaction is when another medicine, food or drink (including alcohol) changes how strongly a medicine works, or changes its side effects in some way.
The interaction may be with a food or food supplement, another prescription or over-the-counter medicine, or a natural or herbal remedy.
Do not stop taking dabigatran without talking to your doctor. This puts you at greater risk of developing a blood clot and having a stroke.
Dabigatran interacts with some other medicines, but it doesn’t appear to interact with foods.
If you are taking dabigatran, you should talk to your doctor or pharmacist before taking any other medicine, including those from a supermarket or health food store.
Medicines that can interact with dabigatran and increase your risk of bleeding include:
Paracetamol (Panadol, Panamax) does not interact with dabigatran and can be used to treat headache, pain or fever.
Tell your doctor, pharmacist and dentist that you’re taking dabigatran. They may need to talk to the doctor who prescribed dabigatran for you, particularly if you need to have surgery.
Warfarin has been used to prevent stroke for over 50 years. It is very effective, but it may take some time to get the dose right.
If you take warfarin, you need to have a regular blood test (called an INR test) to monitor its effect.
If your INR is too high, your blood is taking too long to clot and your risk of bleeding increases. If it is too low, your blood is clotting too quickly. Your warfarin dose may need to be adjusted based on your results.
Your INR is affected by many other medicines as well as certain foods. If you start taking warfarin, you need to be careful not to make big changes to your diet.
Warfarin’s effect can sometimes vary, so it’s important to have regular blood tests to make sure that it’s working well. Studies have shown that dabigatran’s effect is more predictable, so regular blood tests aren’t needed.
Your doctor will help you weigh up the potential benefits and harms of dabigatran and warfarin.
In clinical trials, dabigatran prevented more strokes overall than warfarin. However, because warfarin is very effective, the improvement with dabigatran was small.
People who took their warfarin regularly in clinical trials — and had good blood test (INR) results — appeared to be less likely to benefit from switching to dabigatran.
So bear this in mind if you are doing well on warfarin therapy.
People taking dabigatran do not need regular blood tests, whereas people taking warfarin do.
Some people find these tests bothersome. But others like the opportunity to discuss their progress with their health professional and check that the warfarin is working.
Fewer medicines interact with dabigatran than with warfarin. And, unlike warfarin, there are no dietary restrictions with dabigatran.
Serious bleeding needs urgent hospital treatment because it may be life-threatening.
In a clinical trial comparing dabigatran with warfarin, the number of people who had a serious bleed each year was similar with both medicines — about 3 or 4 out of every 100 people (3% to 4 %).
But remember — you will only be prescribed dabigatran or warfarin if the benefit is thought to outweigh the risk of serious bleeding.
Warfarin has been used for many years so its benefits and side effects are well known. Dabigatran is a very new medicine, and less is known about its long-term safety.
Most medicines prescribed by your doctor are covered by the Pharmaceutical Benefits Scheme (PBS). This means that the Australian Government pays part of the cost of your medicine.
You will need to pay the full price if the medicine is not available on the PBS, or is not available on the PBS for your specific condition.
Dabigatran is used in two different ways:
Some of the risk factors for stroke, like age, gender and medical conditions (such as atrial fibrillation), are things you can’t change. However, there are several lifestyle-related risk factors that you can control.
Your doctor can help you monitor and manage medical conditions that increase your risk of having a stroke. These include high blood pressure, diabetes and high blood cholesterol.
Keeping fit is important for so many aspects of your health. You don’t need to take part in organised sport or exercise classes to do this. Just walking or generally being more active will be of benefit.
Remember that if you are taking dabigatran or warfarin you need to be careful to avoid activities that increase your risk of injury.
Fresh rather than processed foods are much better for you. A healthy diet has lots of different vegetables, fruit and whole grains and limits the amount of sugary, salty and fatty foods.
People who drink heavily are three times more likely to have a stroke. Limit your alcohol intake to two drinks a day and have at least two alcohol-free days every week.
Smoking is a major risk factor for stroke. If you smoke, get help to stop now. Talk to your doctor or call Quitline on 137 848.
Second-hand smoke from other people’s cigarettes is also harmful and you should try to avoid it.
The FAST test is an easy way to remember and recognise the signs of stroke. FAST stands for Face, Arms, Speech and Time to act.
If you see any of these signs, call 000 straight away.
The signs of stroke may occur alone or in combination and they can last a few seconds or up to 24 hours and then disappear.
The Stroke Foundation has more information about the risk factors for stroke and how it can be prevented.
The CMI for Pradaxa (dabigatran) will tell you:
You can get the CMI leaflet for Pradaxa from:
NPS works with healthdirect Australia to provide consumers with information on medicines.
To get information about dabigatran, call 1300 MEDICINE (1300 633 424) from anywhere in Australia for the cost of a local call (excluding mobiles). This service is available Monday to Friday, 9am–5pm EST, with the exception of NSW public holidays.
Call the Adverse Medicine Events (AME) Line on 1300 134 237 (Monday to Friday, 9am–5pm EST).
The AME Line lets you report and discuss side effects that might be related to your medicine. The side effects of your medicine — but not your personal details — are reported to the Australian medicines regulatory agency (the Therapeutic Goods Administration or TGA for short). The information helps to improve the safe use of medicines.
The Australian Self Medication Industry (ASMI) provides more information on understanding side effects.
NPS acknowledges the contribution of the Heart Foundation and the Stroke Foundation in the production of this article.

Date published: 2011-08-05 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.